(Health-NewsWire.Net, November 03, 2017 ) The North America Protein Labelling Market was worth USD 0.46 billion in 2016 and estimated to be growing at a CAGR of 13.56%, to reach USD 0.88 billion by 2021. Protein labelling is done using labelling reagents and kits to label an antibody or other protein, to make an enzyme conjugate, fluorescent probe, biotinylated binding reagent or iodine-labelled tracer for detecting proteins in tissues, cells, and biochemical assays.
Browse report details @ http://www.marketdataforecast.com/market-reports/north-america-protein-labelling-market-3071/
The labelling techniques find applications in various biotechnological and pharmaceutical research and diagnostic processes that include protein micro assay, cell-based assay, mass spectrometry, fluorescence microscopy and immunological techniques. The major players in the market have the product portfolio which includes various reagents, kits & services for in-vitro and in-vivo labelling of the specific peptides. Development of advanced dyes that rapidly conjugates with the specific peptides in order to detect their presence and further the purification process more accurately are expected to have a positive impact on growth.
Market Conditions: The North America market is witnessing a number of new product launches and improvement in existing technologies that are predicted to accelerate growth in demand. Growing adoption of bioengineering technologies, increasing health care awareness and growing investments in R&D. Moreover, growing proteomics research is boosting the market growth.
North America Protein Labelling Market Segmentation: • By Product: Introduction, Reagents (Enzymes, Monoclonal Antibodies, Proteins, Probes/Tags and Others ), Kits and Services • By Labeling Method: Introduction, In vitro Labeling (Enzymatic Labeling, Dye-Based Labeling, Cotranslational Labeling, Site-Specific Labeling and Nanoparticle Labeling), In vivo Labeling (Photoreactive Labeling and Radioactive Labeling) and Bioorthogonal Labeling • By Application: Introduction, Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique and Protein Microarray • By End-User: Introduction • By Geography: Introduction, United States and Canada
North America is the most lucrative region accounting for over 38% of the global revenue in 2016. The market is increasing at a CAGR of 13.56%. Presence of most major players in the region working on enhancing their portfolios on offer and rise in adoption of protein labelling in tandem with the development of genomic sequencing and personalized medicine are the major factors accounting for the region’s dominant position.
Current Key Players of this Market: The Key companies dominating the North America protein labelling market are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
Avail Free Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/north-america-protein-labelling-market-3071/request-sample
About MarketDataForecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact: Abhishek Shukla International Business Development Manager Market Data Forecast Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|